Novavax hopes its COVID shot wins over FDA, vaccine holdouts
2 years, 6 months ago

Novavax hopes its COVID shot wins over FDA, vaccine holdouts

Associated Press  

— Americans may soon get a new COVID-19 vaccine option -- shots made with a more tried-and-true technology than today’s versions. “What I’ve seen of the Novavax data so far is it’s a really impressive protein vaccine,” said University of Pennsylvania immunologist E. John Wherry. Novavax, a small biotech company, created the vaccine in its research lab, but the Serum Institute of India, the world’s largest vaccine maker and other factories produce the shots. While none of the world’s COVID-19 vaccines have proved as strong against omicron, Glenn said lab tests show Novavax shots do trigger cross-protective antibodies. On June 7, the FDA’s scientific advisers will publicly evaluate evidence backing the Novavax vaccine for adults -- and almost certainly will debate when and how it might be used as a booster.

Europe Fda Vaccine Glenn Shots Novavax Shot  vaccine  omicron  research  holdouts  covid  wins  shots  vaccines  hopes  spike  used  protein  company  fda  novavax  shot

History of this topic

FDA approves updated COVID-19 vaccines; shots should be available in days
4 months ago

FDA approves updated COVID-19 vaccines; shots should be available in days

LA Times  

With the Food and Drug Administration’s clearance, Pfizer and Moderna are set to begin shipping millions of doses of the new COVID019 vaccine. U.S. regulators approved updated COVID-19 vaccines on Thursday, shots designed to more closely target recent virus strains — and hopefully whatever variants cause trouble this winter too. “We strongly encourage those who are eligible to consider receiving …

FDA advisers urge targeting JN.1 strain in recipe for fall’s COVID vaccines
6 months, 2 weeks ago

FDA advisers urge targeting JN.1 strain in recipe for fall’s COVID vaccines

Associated Press  

WASHINGTON — Government advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall -- targeting a version of the ever-evolving coronavirus called JN.1. But just a few months later, numerous offshoots of JN.1 already are on the rise, prompting Moderna and Pfizer to also test a slightly different vaccine formula targeting …

AstraZeneca pulls its COVID-19 vaccine from the European market
7 months, 2 weeks ago

AstraZeneca pulls its COVID-19 vaccine from the European market

Associated Press  

LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.” AstraZeneca’s COVID-19 vaccine was first given …

Newest COVID shots are 54% effective in preventing symptoms, CDC finds
10 months, 3 weeks ago

Newest COVID shots are 54% effective in preventing symptoms, CDC finds

Associated Press  

NEW YORK — The latest versions of COVID-19 vaccines were 54% effective at preventing symptomatic infection in adults, according to the first U.S. study to assess how well the shots work. The 54% finding is similar to what’s been reported in other countries, and it’s also about what was reported for an earlier vaccine version, said the Ruth Link-Gelles of …

Novavax’s COVID-19 vaccine gets the green light from the FDA, giving third option for protection
1 year, 2 months ago

Novavax’s COVID-19 vaccine gets the green light from the FDA, giving third option for protection

Salon  

On Tuesday, the Food and Drug Administration authorized the use of a new Novavax vaccine specifically targeted to protect against the latest Omicron circulating strains. Following a bumpy rollout of the Moderna and Pfizer vaccines, it will bring another option to the table for those who are ready to roll up their sleeves and get vaccinated amid a rise in …

Updated COVID vaccines will be available later this week, recommended for everyone six months and up
1 year, 3 months ago

Updated COVID vaccines will be available later this week, recommended for everyone six months and up

Salon  

A new, fourth round of COVID-19 booster shots was approved Tuesday, following the recommendation of federal health agencies, which will make the vaccines available to Americans later this week. The Centers for Disease Control and Prevention followed suit this afternoon, with CDC director Mandy Cohen recommending updated vaccination for "everyone 6 months and older to better protect you and your …

Should you get the new COVID booster? The CDC is about to decide
1 year, 3 months ago

Should you get the new COVID booster? The CDC is about to decide

LA Times  

A nurse prepares a syringe of a COVID-19 vaccine. The CDC’s vaccine advisors will soon decide whether to recommend the latest COVID-19 boosters only for frail, older, sick and immunocompromised people or to offer it to everyone over 6 months of age. “I don’t plan to get it myself,” said Dr. Paul Offit, the director of the Vaccine Education Center …

COVID-19 vaccine maker Novavax to chop workforce, expenses
1 year, 7 months ago

COVID-19 vaccine maker Novavax to chop workforce, expenses

Associated Press  

Novavax is cutting about a quarter of its global workforce as the COVID-19 vaccine maker seeks to slash expenses while dealing with uncertain future revenue. The company said Tuesday that it expects to trim next year’s costs for research and development as well as selling, general and administrative expenses by about 40% to 50% compared to 2022. A Novavax representative …

CDC signs off on additional Covid-19 booster doses for certain people
1 year, 8 months ago

CDC signs off on additional Covid-19 booster doses for certain people

CNN  

CNN — The US Centers for Disease Control and Prevention updated its recommendations on the Covid-19 vaccines on Wednesday to allow another dose of the bivalent booster for people who are 65 and older or who have weakened immune systems and who “want the option of added protection” against the coronavirus. The move aligns with Tuesday’s US Food and Drug …

Covovax to be available on CoWIN as booster dose soon. Check details
1 year, 8 months ago

Covovax to be available on CoWIN as booster dose soon. Check details

Hindustan Times  

In view of rising cases of COVID-19 in various parts of the country, Union Health Minister Mansukh Mandaviya is learnt to have approved the inclusion of Serum Institute’s Covovax on the CoWIN portal as a heterologous booster dose for adults, official sources said on Monday. According to an official source, Singh had mentioned in his letter to the ministry that …

FDA advisers set to consider one-and-done annual covid booster plan
1 year, 10 months ago

FDA advisers set to consider one-and-done annual covid booster plan

Live Mint  

The message has come through loud and clear that Americans have already had enough of frequent Covid shots. The new strategy would require health officials to meet each year to review which strains of the virus should be included in the shots, just as they do with flu, for use in September. “I don’t think that we can chase after …

FDA’s advisors back plan to simplify COVID-19 vaccinations
1 year, 10 months ago

FDA’s advisors back plan to simplify COVID-19 vaccinations

LA Times  

Syringes with COVDI-19 vaccines are prepared at a free public clinic in Lynwood last year. “We’re still protected against severe disease, thank goodness,” even after the latest Omicron strains cropped up, said FDA advisor Dr. Paul Offit, a vaccine expert at Children’s Hospital of Philadelphia. The first step: The FDA advisory panel voted unanimously that people should get the same …

DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose
1 year, 11 months ago

DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose

News 18  

The Drug Controller General of India has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin, official sources said on Monday. Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India, had recently written to the DCGI for the approval …

SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose
2 years ago

SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose

News 18  

The Serum Institute of India has sought the drug regulator’s approval for market authorisation of its COVID-19 vaccine Covovax as a booster dose for those aged 18 years and above who have been administered two doses of Covishield or Covaxin, official sources said on Thursday. Prakash Kumar Singh, director, government and regulatory affairs, SII, submitted a market authorisation application for …

As COVID-19 spikes in California, booster shots could make all the difference
2 years ago

As COVID-19 spikes in California, booster shots could make all the difference

LA Times  

With coronavirus cases and hospitalizations rising in Los Angeles County, officials are voicing new confidence in the effectiveness of the updated COVID-19 booster shot. New data has found that the updated COVID-19 vaccines offer “significant additional protection” against symptomatic infection in people who were previously vaccinated or boosted with the older formula. “We have seen very low uptake of the …

U.S. clears Novavax vaccine for use as COVID-19 booster
2 years, 2 months ago

U.S. clears Novavax vaccine for use as COVID-19 booster

LA Times  

A vial of the COVID-19 vaccine made by Novavax. U.S. regulators on Wednesday authorized a booster dose of the COVID-19 vaccine made by Novavax. The Food and Drug Administration said the new booster option is for people 18 and older who can’t get the Omicron-targeting boosters from Pfizer-BioNTech or Moderna for medical or accessibility reasons — or who otherwise would …

FDA vaccine adviser says healthy young people SHOULDN'T get another COVID booster
2 years, 3 months ago

FDA vaccine adviser says healthy young people SHOULDN'T get another COVID booster

Daily Mail  

A top vaccine expert and pediatric doctor is cautioning parents of healthy young people to hold off getting the new COVID booster shot, saying it can carry risks and its efficacy hasn't yet been proven. But writing in the Wall Street Journal earlier this week, Offitt said preliminary data suggested the new bivalent vaccines were actually worse at warding off …

Tweaked COVID boosters close but how much will they help?
2 years, 3 months ago

Tweaked COVID boosters close but how much will they help?

Associated Press  

COVID-19 vaccines tweaked to better match today’s omicron threat are expected to roll out in a few weeks but still up in the air is how much benefit the booster shots will offer, who should get one -- and how soon. Dr. Peter Marks, the FDA’s vaccine chief, said Thursday that once authorized, the tweaked boosters could help right away …

CDC endorses more traditional Novavax COVID shot for adults
2 years, 5 months ago

CDC endorses more traditional Novavax COVID shot for adults

Associated Press  

U.S. adults who haven’t gotten any COVID-19 shots yet should consider a new option from Novavax -- a more traditional kind of vaccine, health officials said Tuesday. THE NOVAVAX DIFFERENCE All of the vaccines used in the U.S. train the body to fight the coronavirus by recognizing its outer coating, the spike protein -- and the first three options essentially …

CDC endorses more traditional Novavax COVID-19 shot
2 years, 5 months ago

CDC endorses more traditional Novavax COVID-19 shot

LA Times  

A dish with syringes containing the Novavax COVID-19 vaccine sits in a refrigerator ready for use. U.S. adults who haven’t gotten any COVID-19 shots yet should consider a new option from Novavax — a more traditional kind of vaccine, health officials said Tuesday. The Novavax difference All of the vaccines used in the U.S. train the body to fight the …

The CDC endorses Novavax, a more traditional COVID vaccine, for adults
2 years, 5 months ago

The CDC endorses Novavax, a more traditional COVID vaccine, for adults

NPR  

The CDC endorses Novavax, a more traditional COVID vaccine, for adults Enlarge this image toggle caption Georg Wendt/AP Georg Wendt/AP U.S. adults who haven't gotten any COVID-19 shots yet should consider a new option from Novavax — a more traditional kind of vaccine, health officials said Tuesday. The Novavax difference All of the vaccines used in the U.S. train the …

US regulators OK new COVID-19 shot option from Novavax
2 years, 5 months ago

US regulators OK new COVID-19 shot option from Novavax

Associated Press  

The U.S. is getting another COVID-19 vaccine choice as the Food and Drug Administration on Wednesday cleared Novavax shots for adults. Novavax makes a more traditional type of shot than the three other COVID-19 vaccines available for use in the U.S. -- and one that’s already available in Europe and multiple other countries. Novavax also has submitted data on booster …

COVID-19: US FDA authorises Novavax vaccine for emergency use in adults
2 years, 5 months ago

COVID-19: US FDA authorises Novavax vaccine for emergency use in adults

India TV News  

Highlights US regulators OK new COVID-19 shot option from Novavax vaccine Food and Drug Administration on Wednesday cleared Novavax shots for adults in US Novavax makes more traditional type of shot than three other COVID vaccines available for use in US COVID-19 news : The US is getting another COVID-19 vaccine choice as the Food and Drug Administration on Wednesday …

Will Americans have the right COVID-19 vaccine this fall? Maybe
2 years, 5 months ago

Will Americans have the right COVID-19 vaccine this fall? Maybe

LA Times  

A man walks underneath the marquee of the Alex Theatre in Glendale. Determining which recipe should go into those doses to induce optimal protection — the vaccine’s “composition” — is an exercise in educated guesswork. Getting a timely and accurate fix on all this “is truly a challenge, and it is science at its hardest,” Dr. Peter Marks, the U.S. …

Despite DCGI Nod, Here’s Why Biological E's Corbevax is Not Yet Available for Booster Shots
2 years, 5 months ago

Despite DCGI Nod, Here’s Why Biological E's Corbevax is Not Yet Available for Booster Shots

News 18  

The wait for the roll-out of Biological E’s Corbevax vaccine as a heterologous booster shot may continue for a while, News18.com has learnt. Corbevax was approved for heterologous use as a Covid booster shot by apex drug regulator Drugs Controller General of India in the first week of June. Thankfully, Omicron does not cause severe disease and hence there is …

Covid vaccine effectiveness falls to 0% a year after first series
2 years, 5 months ago

Covid vaccine effectiveness falls to 0% a year after first series

NL Times  

People who have only received the first and second vaccine shots against Covid-19 are barely protected against a coronavirus infection one year after the injections. By that time, vaccine effectiveness falls to 0 percent, according to the RIVM, the Dutch public health institute. Those who received a booster shot in the interim still receive protection against serious symptoms of the …

FDA advisers recommend updating COVID booster shots for fall
2 years, 5 months ago

FDA advisers recommend updating COVID booster shots for fall

Associated Press  

At least some U.S. adults may get updated COVID-19 shots this fall, as government advisers voted Tuesday that it’s time to tweak booster doses to better match the most recent virus variants. Their combination shots, what scientists call “bivalent” vaccines, substantially boosted levels of antibodies capable of fighting that variant, more than simply giving another dose of today’s vaccine. Marks …

FDA advisors recommend updating COVID booster shot formula for fall
2 years, 5 months ago

FDA advisors recommend updating COVID booster shot formula for fall

LA Times  

Advisors to the Food and Drug Administration are recommending that some U.S. adults get a modified COVID-19 booster shot this fall that better matches the recent variants. Some U.S. adults are a step closer to getting updated COVID-19 boosters this fall, as government advisors voted Tuesday that it’s time to tweak the shots to better match the most recent virus …

FDA grapples with whether to modify COVID vaccine for fall
2 years, 5 months ago

FDA grapples with whether to modify COVID vaccine for fall

LA Times  

The Food and Drug Administration will debate Tuesday whether it’s time to update COVID vaccine formulas. “This is science at its toughest,” said FDA vaccine chief Dr. Peter Marks, adding that a final decision is expected within days of the advisory panel’s recommendation. In an analysis prepared for Tuesday’s meeting, FDA officials acknowledged targeting last winter’s version of Omicron is …

FDA advisors back Moderna’s COVID-19 vaccine for older kids
2 years, 6 months ago

FDA advisors back Moderna’s COVID-19 vaccine for older kids

LA Times  

A vial of the Moderna COVID-19 vaccine on a counter at a pharmacy in Portland, Ore. A government advisory panel has endorsed the company’s vaccine for school-age children and teens. Moderna’s COVID-19 vaccine has long been available for adults in the U.S. and elsewhere and more than three dozen countries offer it to children, too. If the FDA authorizes Moderna’s …

FDA advisers to weigh expanding Covid-19 vaccines to younger kids
2 years, 6 months ago

FDA advisers to weigh expanding Covid-19 vaccines to younger kids

CNN  

CNN — Several months after older children became eligible to get vaccinated against Covid-19, the United States might be just days away from offering vaccines to those younger than 5. Pfizer’s data People 5 and older are already eligible for Pfizer/BioNTech’s two-dose Covid-19 vaccine and a booster dose – but in Wednesday’s meeting, VRBPAC members will discuss whether to add …

The Most Common Questions About The Novavax COVID Vaccine, Answered
2 years, 6 months ago

The Most Common Questions About The Novavax COVID Vaccine, Answered

Huff Post  

LOADING ERROR LOADING As scientists and health experts continue to learn how to fight the virus, more treatment and prevention methods are becoming available ― including additional vaccines. Novavax’s COVID-19 shot “is a technology commonly used in most other vaccines, such as flu, hepatitis B and shingles,” said Dr. Mahdee Sobhanie, an infectious diseases physician at Ohio State University Wexner …

New vaccine may be option for troops with religious concerns
2 years, 6 months ago

New vaccine may be option for troops with religious concerns

Associated Press  

WASHINGTON — A COVID-19 vaccine that could soon win federal authorization may offer a boost for the U.S. military: an opportunity to get shots into some of the thousands of service members who have refused other coronavirus vaccines for religious reasons. The Novavax vaccine may be an acceptable option for some of the 27,000 service members who have sought religious …

New COVID-19 vaccine may be option for troops with religious concerns
2 years, 6 months ago

New COVID-19 vaccine may be option for troops with religious concerns

LA Times  

A vial of the the Novavax COVID-19 vaccine is readied for use. A COVID-19 vaccine that could soon win federal authorization may offer a boost for the U.S. military: an opportunity to get shots into some of the thousands of service members who have refused other COVID-19 vaccines for religious reasons. One group involved in lawsuits targeting the military’s vaccine …

FDA advisers back Novavax COVID-19 shots as fourth US option
2 years, 6 months ago

FDA advisers back Novavax COVID-19 shots as fourth US option

Firstpost  

The FDA advisory panel voted that the benefits of two primary Novavax doses outweigh its risks — but they had a lot of questions about the shots’ role at this point in the pandemic. Next, the FDA must decide whether to authorize the protein vaccine made by latecomer Novavax as the nation’s fourth coronavirus shot for adults. FDA’s vaccine chief …

FDA advisers back Novavax COVID shots as 4th US option
2 years, 6 months ago

FDA advisers back Novavax COVID shots as 4th US option

Associated Press  

American adults who haven’t yet gotten vaccinated against COVID-19 may soon get another choice, as advisers to the Food and Drug Administration on Tuesday backed a more traditional type of shot. Next, the FDA must decide whether to authorize the protein vaccine made by latecomer Novavax as the nation’s fourth coronavirus shot for adults. FDA’s vaccine chief Dr. Peter Marks …

FDA advisory panel gives near-unanimous recommendation to Novavax's COVID-19 vaccine
2 years, 6 months ago

FDA advisory panel gives near-unanimous recommendation to Novavax's COVID-19 vaccine

Daily Mail  

Novavax's COVID-19 vaccine received near-unanimous approval for use in adults over 18 years old on Tuesday, paving the way for it to become the fourth jab and first protein-based shot to be rolled out in America. Unlike Pfizer and Moderna's shots, the Novavax jab uses the same protein-based technology as flu vaccines, which expose the immune system to spike proteins …

Advisers to the FDA back Novavax COVID vaccine
2 years, 6 months ago

Advisers to the FDA back Novavax COVID vaccine

NPR  

Advisers to the FDA back Novavax COVID vaccine Enlarge this image toggle caption Karen Ducey/Getty Images Karen Ducey/Getty Images In a 21-0 vote with one abstention, advisers to the Food and Drug Administration recommended that the agency authorize Novavax's two-dose vaccine against COVID-19. In comments to the committee before its vote, Dr. Peter Marks, the FDA's top vaccine official said, …

FDA advisors back Novavax COVID-19 vaccine as a new U.S. option
2 years, 6 months ago

FDA advisors back Novavax COVID-19 vaccine as a new U.S. option

LA Times  

American adults who haven’t yet gotten vaccinated against COVID-19 may soon get another choice, as advisors to the Food and Drug Administration on Tuesday backed a more traditional type of shot. Next, the FDA must decide whether to authorize the vaccine made by latecomer Novavax, a protein vaccine that’s made with a more conventional tech- nology than today’s U.S. options. …

Q&A: Novavax hopes its COVID shot wins over FDA, vaccine holdouts
2 years, 6 months ago

Q&A: Novavax hopes its COVID shot wins over FDA, vaccine holdouts

LA Times  

Americans may soon get a new COVID-19 vaccine option — shots made with a more tried-and-true technology than today’s versions. “What I’ve seen of the Novavax data so far is it’s a really impressive protein vaccine,” said University of Pennsylvania immunologist E. John Wherry. Novavax, a small biotech company, created the vaccine in its research lab, but the Serum Institute …

With old-school technology, can Novavax win over COVID vaccine skeptics?
2 years, 7 months ago

With old-school technology, can Novavax win over COVID vaccine skeptics?

LA Times  

A vial of the Novavax COVID-19 vaccine is ready for use in a Phase 3 clinical trial in London. Some people “may prefer tried and true technologies” for COVID-19 vaccines, said Dr. Filip Dubovsky, the chief medical officer of Novavax. It’s even possible a single Novavax shot could target multiple coronavirus variants in one shot, although Dubovsky said it makes …

SII's Covid Vaccine Covovax Now Available for 12-17 Age Group at Private Centres
2 years, 7 months ago

SII's Covid Vaccine Covovax Now Available for 12-17 Age Group at Private Centres

News 18  

Children aged 12 to 17 years can now get the Serum Institute's coronavirus vaccine Covovax at private centres with a provision for it being made on the CoWIN portal, official sources said on Monday. "Those aged 12-17 age group can now opt for Covovax shot at private hospitals. India's drug regulator had approved Covovax for restricted use in emergency situations …

UK clears 6th Covid vaccine despite cancelling deal for doses
2 years, 8 months ago

UK clears 6th Covid vaccine despite cancelling deal for doses

India Today  

British authorities have authorized a coronavirus vaccine for adults made by French drugmaker Valneva, despite the government's decision last year to cancel an order for at least 100 million doses. Britain's medicines regulator said Thursday that the two-dose vaccine is intended for adults ages 18 to 50, with the second dose given about a month after the first. FULL CORONAVIRUS …

Dutch gov’t ordered 840,000 Novavax Covid jabs; Only 1,000 shots used
2 years, 8 months ago

Dutch gov’t ordered 840,000 Novavax Covid jabs; Only 1,000 shots used

NL Times  

The Netherlands purchased 840,000 doses of the Novavax vaccine against Covid-19 for approximately 15 million euros, but nobody seems to want the protein-based vaccine. The government purchased the Novavax vaccines as an alternative for people who don't want to get an mRNA vaccine or vector vaccine against the coronavirus because the techniques behind those are still young. But since March …

Britain approves Moderna's Covid shot for 6-11 year-olds
2 years, 8 months ago

Britain approves Moderna's Covid shot for 6-11 year-olds

India Today  

Britain's medicines regulator on Thursday approved the use of Moderna's Covid-19 vaccine in children between six and 11 years, as the country bolsters itself for fighting coronavirus infections amid the spread of new virus variants. Spikevax was already approved in Britain for those over 12 years, and the extension to include younger children comes hours after the regulator approved French …

Rich countries getting new COVID vaccine before poorer ones despite U.N.-backed initiative
2 years, 9 months ago

Rich countries getting new COVID vaccine before poorer ones despite U.N.-backed initiative

LA Times  

A worker moves boxes carrying Novavax’s COVID-19 vaccine at SK Bioscience Co. in Andong, South Korea, on Feb. 9. Novavax, the company behind a COVID-19 vaccine touted as a key tool for the developing world, will miss a target for giving doses to a U.N.-backed effort to supply shots to poorer countries. The company behind a COVID-19 vaccine touted as …

Rich Countries Getting New COVID Vaccine Before Poorer Ones
2 years, 9 months ago

Rich Countries Getting New COVID Vaccine Before Poorer Ones

Huff Post  

FILE - A worker moves boxes carrying Novavax's COVID-19 vaccine at SK Bioscience Co. in Andong, South Korea, on Feb. 9, 2022. via Associated Press NEW DELHI — The company behind a COVID-19 vaccine touted as a key tool for the developing world has sent tens of millions of doses to wealthy nations but provided none yet to the U.N.-backed …

Rich countries getting new COVID vaccine before poorer ones
2 years, 9 months ago

Rich countries getting new COVID vaccine before poorer ones

Associated Press  

NEW DELHI — The company behind a COVID-19 vaccine touted as a key tool for the developing world has sent tens of millions of doses to wealthy nations but provided none yet to the U.N.-backed effort to supply poorer countries, a sign that inequity persists in the global response to the pandemic. The company, Novavax, got $388 million from one …

Rich countries getting new Novavax COVID-19 vaccine before poorer ones
2 years, 9 months ago

Rich countries getting new Novavax COVID-19 vaccine before poorer ones

LA Times  

The company behind a COVID-19 vaccine touted as a key tool for the developing world has sent tens of millions of doses to wealthy nations but provided none yet to the United Nations-backed effort to supply poorer countries, a sign that inequity persists in the global response to the pandemic. The investment guaranteed COVAX the “right of first refusal” to …

Discover Related